The Research and Development team at Kymera Therapeutics is dedicated to pioneering the discovery and development of innovative small molecule therapeutics that target and degrade disease-causing proteins. Comprising experts in proteomics, medicinal chemistry, biochemical analysis, and translational medicine, the team collaborates to advance drug candidates through rigorous preclinical evaluation, ensuring their efficacy and safety for future clinical trials. Their interdisciplinary approach integrates cutting-edge technologies and scientific expertise to accelerate the path from discovery to impactful therapeutic solutions.
View all